AR and pachyonychia congenita: Overall, the development of this novel CRISPR-mediated knock-in cell line has provided an unequivocal read-out for AR-V transcriptomics and highlighted new modes of AR-V regulation that suggest new pharmacological sensitivities in advanced PC patients who express receptor splice variants.